{
    "Trade/Device Name(s)": [
        "ImmunoCAP Tryptase",
        "ImmunoCAP Tryptase Calibrators",
        "ImmunoCAP Tryptase Curve Control",
        "ImmunoCAP Tryptase Conjugate 50",
        "ImmunoCAP Tryptase Calibrator Strip",
        "ImmunoCAP Tryptase Curve Control Strip"
    ],
    "Submitter Information": "Phadia AB",
    "510(k) Number": "K173704",
    "Predicate Device Reference 510(k) Number(s)": [
        "K103039"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OYL"
    ],
    "Summary Letter Date": "March 2, 2018",
    "Summary Letter Received Date": "December 4, 2017",
    "Submission Date": "December 1, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.5760"
    ],
    "Regulation Name(s)": [
        "Tryptase test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Tryptase"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Lithium heparin tube",
        "Sodium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Phadia 100",
        "Phadia 250"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoassay",
        "Fluorescent enzyme immunoassay"
    ],
    "Methodologies": [
        "Semi-quantitative measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Conjugate",
        "Strip"
    ],
    "Document Summary": "FDA 510(k) summary for ImmunoCAP Tryptase assay and reagents for measurement of tryptase in human serum or plasma to aid in clinical diagnosis of systemic mastocytosis.",
    "Indications for Use Summary": "In vitro semi-quantitative assay to measure tryptase in human serum or plasma as an aid in diagnosing patients suspected of systemic mastocytosis, used with Phadia 100 and Phadia 250 instruments.",
    "fda_folder": "Immunology"
}